(Q30651444)

English

Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

0 references

object named as

Harri Mustonen

4

0 references

Martti Färkkilä

object named as

Martti A Färkkilä

5

0 references

author name string

Urpo Nieminen

1

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Airi Jussila

2

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Stig Nordling

3

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

language of work or name

0 references

publication date

16 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

134

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

189-196

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Colorectal cancer prevention in ulcerative colitis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28346

21 January 2018

Identifiers

10.1002/IJC.28346

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30651444&oldid=1965113977"